Taral Patel

4.0k total citations · 2 hit papers
38 papers, 2.1k citations indexed

About

Taral Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Taral Patel has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Taral Patel's work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Taral Patel is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Taral Patel collaborates with scholars based in United States, Poland and United Kingdom. Taral Patel's co-authors include Michael McCleod, Fairooz F. Kabbinavar, John Hamm, William Novotny, Joseph J. Schulz, R. Mass, J. Randolph Hecht, B. Nelson, Donald Woytowitz and Martin R. Weber and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Scientific Reports.

In The Last Decade

Taral Patel

31 papers receiving 2.0k citations

Hit Papers

Addition of Bevacizumab to Bolus Fluorouracil and Leucovo... 2005 2026 2012 2019 2005 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial
    2005 709 citations Fairooz F. Kabbinavar, Joseph J. Schulz et al. Journal of Clinical Oncology profile →
  2. Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
    2013 370 citations David R. Spigel, Thomas J. Ervin et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taral Patel United States 14 1.4k 1.1k 476 405 263 38 2.1k
Wei‐Xiang Qi China 24 1.1k 0.8× 940 0.9× 426 0.9× 142 0.4× 227 0.9× 109 2.1k
Frank A. Scappaticci United States 22 1.4k 1.0× 856 0.8× 1.2k 2.5× 336 0.8× 470 1.8× 38 2.8k
K. Syrigos Greece 23 1.1k 0.8× 638 0.6× 388 0.8× 158 0.4× 288 1.1× 73 1.9k
Yihebali Chi China 16 1.5k 1.1× 817 0.7× 308 0.6× 203 0.5× 172 0.7× 67 2.0k
Akihito Tsuji Japan 24 1.9k 1.4× 1.6k 1.4× 370 0.8× 325 0.8× 249 0.9× 184 2.8k
Matias Riihimäki Sweden 12 1.4k 1.0× 821 0.8× 348 0.7× 165 0.4× 295 1.1× 12 2.2k
Guy A. Van Hazel Australia 18 1.9k 1.4× 913 0.8× 400 0.8× 909 2.2× 294 1.1× 40 2.4k
Nobuyuki Mizunuma Japan 23 1.5k 1.1× 530 0.5× 506 1.1× 327 0.8× 367 1.4× 133 2.0k
Marianne Krahn Canada 3 1.3k 0.9× 526 0.5× 247 0.5× 249 0.6× 198 0.8× 6 1.8k
Vinod Ganju Australia 24 2.0k 1.4× 906 0.8× 655 1.4× 445 1.1× 447 1.7× 94 2.7k

Countries citing papers authored by Taral Patel

Since Specialization
Citations

This map shows the geographic impact of Taral Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taral Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taral Patel more than expected).

Fields of papers citing papers by Taral Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taral Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taral Patel. The network helps show where Taral Patel may publish in the future.

Co-authorship network of co-authors of Taral Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Taral Patel. A scholar is included among the top collaborators of Taral Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taral Patel. Taral Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Taral, et al.. (2025). Hybrid conducting polymer films promote neural outgrowth and neural-electrode integration in vitro. Bioelectrochemistry. 165. 108985–108985.
2.
Foster, Malcolm, Paul S. Brady, Seth I. Sokol, et al.. (2024). Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV Trial. Journal of the Society for Cardiovascular Angiography & Interventions. 4(1). 102463–102463. 6 indexed citations
3.
Patel, Taral, et al.. (2024). Iodonium-based pro-adhesive layers for robust adhesion of PEDOT:PSS to surfaces. Science and Technology of Advanced Materials. 25(1). 2338786–2338786. 1 indexed citations
4.
Abdullah, Abdullah, et al.. (2024). Surface-Functionalized PEDOT:PSS Interfaces for Improved Adhesion, Viability, and Extracellular Charge Transfer of Shewanella oneidensis MR-1. ACS Sustainable Chemistry & Engineering. 12(52). 18508–18521. 1 indexed citations
5.
Patel, Taral, Jie Huang, & Katarzyna Krukiewicz. (2023). Multifunctional organic monolayer-based coatings for implantable biosensors and bioelectronic devices: Review and perspectives. Biosensors and Bioelectronics X. 14. 100349–100349. 16 indexed citations
6.
Patel, Taral, M. Skorupa, Magdalena Skonieczna, Roman Turczyn, & Katarzyna Krukiewicz. (2023). Surface grafting of poly-L-lysine via diazonium chemistry to enhance cell adhesion to biomedical electrodes. Bioelectrochemistry. 152. 108465–108465. 8 indexed citations
7.
Patel, Taral, Magdalena Skonieczna, Roman Turczyn, & Katarzyna Krukiewicz. (2023). Modulating pro-adhesive nature of metallic surfaces through a polypeptide coupling via diazonium chemistry. Scientific Reports. 13(1). 18365–18365. 5 indexed citations
8.
Kim, Edward S., Balázs Halmos, Taral Patel, et al.. (2017). Efficacy and Safety Results of the Afatinib Expanded Access Program. Oncology and Therapy. 5(1). 103–110. 4 indexed citations
9.
Zeng, Ming, Taral Patel, Mark Knapp, et al.. (2016). Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma. World Journal of Gastrointestinal Oncology. 8(5). 474–474. 6 indexed citations
10.
Kabbinavar, Fairooz F., Louis Fehrenbacher, John D. Hainsworth, et al.. (2014). Biomarker Analyses from a Randomized, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab with or without Erlotinib as Maintenance Therapy for the Treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS). Journal of Thoracic Oncology. 9(9). 1411–1417. 13 indexed citations
11.
Greenwald, Daniel, Hailun Li, Selina M. Luger, et al.. (2013). A phase II study of sorafenib (BAY 43–9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404). Journal of Hematology & Oncology. 6(1). 46–46. 10 indexed citations
12.
Cortés, Javier, Sandra M. Swain, Iveta Kudaba, et al.. (2013). Absence of pharmacokinetic drug–drug interaction of pertuzumab with trastuzumab and docetaxel. Anti-Cancer Drugs. 24(10). 1084–1092. 19 indexed citations
13.
Shen, Sharon, Prashant D. Bhave, Taral Patel, et al.. (2012). Prevalence and Predictors of Cable Extrusion and Loss of Electrical Integrity with the Riata Defibrillator Lead. Journal of Cardiovascular Electrophysiology. 23(11). 1207–1212. 32 indexed citations
14.
Spigel, David R., Thomas J. Ervin, Rodryg Ramlau, et al.. (2011). Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC.. Journal of Clinical Oncology. 29(15_suppl). 7505–7505. 149 indexed citations
15.
Weinsaft, Jonathan W., Shant Manoushagian, Taral Patel, et al.. (2008). Stress-induced ST-segment deviation in relation to the presence and severity of coronary artery disease in patients with normal myocardial perfusion imaging. Coronary Artery Disease. 20(1). 41–49.
16.
17.
Frutkin, Andrew D., Sameer K. Mehta, Taral Patel, et al.. (2007). Outcomes of 1,090 Consecutive, Elective, Nonselected Percutaneous Coronary Interventions at a Community Hospital Without Onsite Cardiac Surgery. The American Journal of Cardiology. 101(1). 53–57. 23 indexed citations
18.
Patel, Taral, Anthony A. Bavry, Dharam J. Kumbhani, & Stephen G. Ellis. (2006). A Meta-Analysis of Randomized Trials of Rescue Percutaneous Coronary Intervention After Failed Fibrinolysis. The American Journal of Cardiology. 97(12). 1685–1690. 25 indexed citations
19.
Kabbinavar, Fairooz F., Joseph J. Schulz, Michael McCleod, et al.. (2005). Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial. Journal of Clinical Oncology. 23(16). 3697–3705. 709 indexed citations breakdown →
20.
Patel, Taral & Kenneth C. Goldberg. (2004). Use of Aspirin and Ibuprofen Compared With Aspirin Alone and the Risk of Myocardial Infarction. Archives of Internal Medicine. 164(8). 852–852. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Xiang Qi Breakdown of academic impact, for papers by Frank A. Scappaticci Breakdown of academic impact, for papers by K. Syrigos Breakdown of academic impact, for papers by Yihebali Chi Breakdown of academic impact, for papers by Akihito Tsuji Breakdown of academic impact, for papers by Matias Riihimäki Breakdown of academic impact, for papers by Guy A. Van Hazel Breakdown of academic impact, for papers by Nobuyuki Mizunuma Breakdown of academic impact, for papers by Marianne Krahn Breakdown of academic impact, for papers by Vinod Ganju
Rankless by CCL
2026